Hunting Hill Global Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Hunting Hill Global Capital’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42,454	Closed	-$1.97M	–	143
2023 Q2	$1.97M	Buy	+42,454	New	+$1.47M	0.63%	22

Hunting Hill Global Capital's DICE Position: Q3 2023 in Review

Hunting Hill Global Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 42,454 shares — an estimated $1.97M sold.

Hunting Hill Global Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.97M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Hunting Hill Global Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Hunting Hill Global Capital sold 42,454 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.97M.
Hunting Hill Global Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Hunting Hill Global Capital's DICE Therapeutics, Inc. Common Stock position peaked at $1.97M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Hunting Hill Global Capital's 13F filing for Q3 2023, filed 14 Nov 2023.